Medscape Medical News February 21, 2025 Does Taking ‘The Pill’ Reduce Ovarian Cancer Risk? Medscape Medical News February 21, 2025 Is Disease Activity in IBD a Risk for C difficile Infection? Medscape News UK February 21, 2025 Teva Pharma and Alvotech Launch Biosimilar to J&J's Stelar...
Will Pharma Continue Efforts to Diversify Clinical Trials? Medscape Medical News February 26, 2025 The federal crackdown on DEI initiatives is unlikely to deter companies from designing more representative trials, as it’s ‘good science, good ethics, and good business,’ one expert said. What ...
Get the latest News & Research on Pharma industry, Viewpoints, Events, Videos, statistics, indianpharmapost.com
Medscape News UKFebruary 21, 2025 Teva Pharma and Alvotech Launch Biosimilar to J&J's Stelara in US Reuters Health InformationFebruary 21, 2025 Trendingon Medscape 1 Clinic Death Raises Questions About Oxygen Therapy 2 The Hidden Curriculum in Medical School: What They Dont Teach You ...
Medscape Medical NewsFebruary 26, 2025 Will Pharma Continue Efforts to Diversify Clinical Trials? Medscape Medical NewsFebruary 26, 2025 REPORTS Trends From Surveys of Physicians and Other Medical Professionals ConferencesView All ECC0 2025 February 19-22, 2025Berlin, Germany ...
Get all the latest news about pharmaceutical stocks across the world. Stay up to date with everything affecting pharmaceutical stock prices so you can invest your money wisely
In the NewsPress Releases FEATURED PRESS RELEASE January 22, 2025 Tris Pharma Announces Positive Results from ALLEVIATE-1 Phase 3 Clinical Trial of Cebranopadol, an Investigational First-in-Class Oral Dual-NMR Agonist, for the Treatment of Moderate-to-Severe Acute PainJanuary...
[Pharmabiz] Merck signs MoU with RGCIRC to enhance cancer care access through its flagship Umeed program [BioVoice News] Merck Healthcare signs MoU with Rajiv Gandhi Cancer Institute and Research Centre [BioSpectrum] Merck Healthcare signs MoU with Rajiv Gandhi Cancer Institute and Research Centre ...
Medical Darpan Media House is the fastest growing health & pharma news portal in India. Stay tuned to read all the authentic latest updates in Pharma Industry. Now read in Hindi also.
In Vivo - February 19, 2025 Arcus’s Casdatifan Differentiates, But Data Overshadowed By Gilead Opting Out With new Phase I/Ib results in kidney cancer, the HIF-2a inhibitor outshines Merck’s Welireg, but longtime Arcus partner Gilead decided not to exercise its option for casdatifan. ...